Perioperative pain management stands at the intersection of clinical necessity ethical responsibility and public health urgency because postoperative pain is both a leading cause of patient suffering and a major driver of opioid exposure. Over the last two decades scientific attention has increasingly converged on multimodal analgesia opioid stewardship and anesthetic agents that provide analgesia sedation and organ protection without long term neurotoxicity. Within this evolving field propofol occupies a unique position as both a foundational anesthetic agent and a biologically active neuropharmacological compound with far reaching implications for inflammation neuronal survival synaptic integrity and postoperative cognitive outcomes. Simultaneously bibliometric investigations of perioperative analgesia opioid free anesthesia and pain research have revealed rapid expansion thematic diversification and increasing international collaboration indicating that this domain is not only clinically important but also structurally central to modern biomedical research. This article integrates these two dimensions bibliometric structure and biological substance by synthesizing recent large scale bibliometric analyses of multimodal analgesia opioid free anesthesia and pain science with translational evidence on propofol from cellular animal and clinical domains. Drawing exclusively on the provided references the study constructs a comprehensive narrative that explains how trends in scientific production reflect deeper theoretical transformations in pain management paradigms and how propofol emerges as a core node linking anesthesia analgesia and neuroprotection. Using a descriptive bibliometric methodology grounded in prior large scale mapping studies this article reconstructs research frontiers thematic clusters and citation networks that shape current knowledge production. The results demonstrate that multimodal analgesia and opioid stewardship are now structurally dominant themes in perioperative research while opioid free anesthesia has emerged as a rapidly expanding frontier. Within this ecosystem propofol functions not merely as an anesthetic but as a modulatory agent influencing ischemia reperfusion injury neuronal apoptosis synaptic preservation and electrophysiological monitoring fidelity. The discussion situates these findings within a broader epistemological shift from symptom suppression to systems level regulation of pain and recovery. The article concludes that future perioperative pain management will be defined by the integration of bibliometrically dominant multimodal frameworks with biologically informed anesthetic strategies centered on agents such as propofol that align analgesic efficacy with neurobiological sustainability.